Ettl, Tobias <br/><br/>
EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.  [electronic resource] 

 -  Human pathology  Jun 2012 
 - 921-31 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-8392 
<br/><br/><label>Standard No.: </label>10.1016/j.humpath.2011.08.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--analysis<br/>Carcinoma--genetics<br/>ErbB Receptors--analysis<br/>Female<br/>Gene Dosage<br/>Genes, erbB-1<br/>Genes, erbB-2<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Inhibitor of Apoptosis Proteins--analysis<br/>Kaplan-Meier Estimate<br/>Male<br/>Neoplasm Staging<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--analysis<br/>STAT3 Transcription Factor--analysis<br/>Salivary Gland Neoplasms--genetics<br/>Survivin<br/>Tissue Array Analysis